|
|
 |
|
Viewing report
|
|
|
|
Disease & Therapy Review (DTR) Executive Market Summaries
Timely Data Resources, Inc., Feb 2012
Disease & Therapy Review is meant to be an accurate and efficient executive synopsis of the indications that IPD users look up most frequently. Each report includes epidemiology from the IPD (Incidence and Prevalence Database), treatment data and charts, market data and drug cost when available. The reports are collaboration between our epidemiological specialists and senior market research analysts who each have over 15 years of experience.
Reports currently available include:
- Crohn's Disease
- End Stage Renal Disease
- Epilepsy
- Heart Failure
- Hepatitis B
- Hypercholesterolemia
- Hypertension
- Multiple Sclerosis
- Obesity
- Parkinson's Disease
- Rheumatoid Arthritis
- Stroke
Note: Subscriptions include full access to all DTR reports as well as access to the senior analyst who wrote any of the reports for further questions or comments.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Disease and Therapy Review: Generalized Anxiety Disorder (GAD)
Disease and Therapy Review: Diabetes
The Incidence and Prevalence Database: Global Incidence, Prevalence, Morbidity, Comorbidity, Cost Data, Symptoms and Many Other Health Issues for over 4,700 Diseases and Procedures
Ulcerative Colitis – Executive Market Summary 2011
Disease and Therapy Review: Attention Deficit Hyperactivity Disorder (ADHD)
Disease and Therapy Review: Myocardial Infarction
Disease and Therapy Review: Angina Pectoris
Onychomycosis – Executive Market Summary 2011
Chemotherapy Market Insights, 2006-2016: A Critical Analysis of Cancer Research, Treatments, Pipelines, and Commercial Opportunities
Cystic Fibrosis: Will New Agents Emerge as First-Line Therapies?
|
|
|
|
